HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Glioblastoma · Anaplastic Astrocytoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Houston Methodist Neurological Institute, Houston, Texas, United States
Contact: Study coordinator (David S. Baskin, MD) · DBaskin@houstonmethodist.org · 713-441-3800
Contact: Study coordinator (Helga M. Jones) · HMJones@houstonmethodist.org · 713-363-9388

Study leads

David S. Baskin, MD
Principal Investigator
Houston Methodist Neurological Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

IDH1 wt Allele · Recurrent Anaplastic Astrocytoma · Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Houston, United States

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

Glioblastoma Multiforme · Astrocytoma, Grade III

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Malignant Glioma of Brain · Astrocytoma · Malignant Astrocytoma

Abroad (travel likely)RecruitingPHASE1

Detroit, United States

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States